Research and Markets


Printer Friendly

Printed from http://www.researchandmarkets.com/reports/656024


The North America Biotechnology Sectors : A Company and Industry Analysis (August 2005)


Description: This report looks at the biotechnology industry in the United States and Canada
Current Environment - Key Points
- The US biotech industry ended on a high note in the closing months of 2004 but some high-profile product failures in recent months heightened safety concerns and pulled the sector down in the first quarter of 2005
- Leading companies in the US continue to record revenue growth and profits owing to stronger demand of products
They are also effectively discovering new indications for their products, especially in the area of oncology
- Biotech companies in both US and Canada are actively consolidating and forming partnerships
Pharmaceuticals in both countries are increasingly turning to biotech companies to fill their starving pipelines
- Canadian biotechs are showing signs of maturity with revenue increases of 21% in 2004 and a fall in losses by 30%
More and more companies are moving toward clinical trials and filing for product approvals

Industry Profile - Key Points
- The US continues to dominate the biotech industry globally, generating sales of $50 billion compared with $8 billion in 1992
Canada, though still falling behind the US, is ranked first in the world in terms of R&D expenditure and third in terms of revenue generation behind the US and Britain
- US biotech market capitalization rose to $400 billion in 2004 from $344 billion in 2003, up 16%, according to the index of US biotech companies tracked by Burril & Company, a life sciences merchant bank
- The US regulatory environment seems to be tightening to enhance drug safety and may lengthen future product approvals by the FDA
- Biotech financing in the US and Canada was relatively solid in the past six months, largely owing to biotech's strong underlying fundamentals
April and May saw a significant amount of venture capital poured into Canadian biotechs at home and abroad
- The biotech industry in the US and Canada continue to garner more and more investments from the private and public sector as well as their governments
Market Trends and Outlook - Key Points
- Rising drug costs in the US are encouraging drug importation from Canada and undercutting US sales of drugs
- Targeted therapies in the US are gaining in importance and are being applied to biotech drug development, leading manufacturers to move away from the traditional -one-size-fits-all- drugs to more specialized solutions
- The US biotech industry is poised for profitability with many biotech products quickly moving out of the pipeline and into the marketplace
- Much is being done in Canada to attract and retain skilled workers
- Escalating health-care costs in Canada could lead the Government to relax regulations to allow cheaper generics to enter the market and replace costly branded biotech drugs
- Canada's history of biotech innovation, its excellent reputation, massive government support and favorable tax incentives will drive the industry to success


Contents: Current Environment -US
- Sector Overview
- Sector Performance
- Leading Companies
- Mergers, Acquisitions and
Alliances
- Initial Public Offerings
Current Environment - Canada
- Sector Overview
- Sector Performance
- Leading Companies
- Mergers, Acquisitions and
Alliances
- Initial Public Offerings
Industry Profile - US
- Industry Size and Value
- Industry Focus
- Sector Investment
- Policy and Regulatory
Environment
Industry Profile - Canada
- Industry Size and Value
- Industry Focus
- Sector Investment
- Policy and Regulatory
Environment
Market Trends and Outlook - US
- Rising Drug Costs Increase
Imports
- Moving Toward Targeted
Healthcare Solutions
- Convergence of Technology
- Increasing Global Acceptance of
Agri-biotech
- Increasing Global Competition
- Market Outlook
Market Trends and Outlook -
Canada
- Attracting and Raising a
Competent Biotech Workforce
- Escalating Healthcare Costs
- Biotech-biotech Partnering
- Market Outlook
Currency Conversion Table
The Scope of This Report
Key References
Comparative Data
Regional Reports Coverage




Ordering: Order Online - visit http://www.researchandmarkets.com/reports/656024

Order by Fax - using the order form below

Order By Post - print the order form below and send to

Research and Markets,
Guinness Centre,
Taylors Lane,
Dublin 8,
Ireland.


Research and Markets Page 1 of 2
Printed 22/11/2009 22:30:09
Fax Order Form
To place an order via fax simply print this form, fill in the information below and fax the completed form to
646-607-1907 (from USA) or +353 1 6849977 (from Rest of World). If you have any questions please email help@researchandmarkets.net

Order information
Please verify that the product information is correct and select the format you require.
Product Name:
The North America Biotechnology Sectors : A Company and Industry Analysis (August 2005)
Web Address:
http://www.researchandmarkets.com/reports/656024
Office Code:
OC8HJMSMOVUUX

Report formats
Please enter the quantity of the report format you require.

Format Quantity Price
Electronic (PDF) - Single User €100.00



Contact information
Please enter all the information below in BLOCK CAPITALS.

First Name:   Last Name:  
Email Address:
Job Title:
Organisation:
Address:
City:
Postal/Zip Code:
Country:
Phone Number:
Fax Number:


Please fax this form to:
(646) 607-1907 or (646) 964-6609 (from USA)
+353-1-481-1716 or +353-1-653-1571 (from Rest of World)
Research and Markets Page 2 of 2
Printed 22/11/2009 22:30:09

Payment information

Please indicate the payment method you would like to use by selecting the appropriate box.

 Pay by Credit Card:
American Express
Diners Club
Master Card
Visa
Cardholder's Name:
Cardholder's Signature:
Expiry Date: /
Card Number:
CVV Security Code:
Issue Date: /   (Diners Club only)


 Pay by Check:
Please post the check, accompanied by this form, to:

Research and Markets,
Guinness Centre,
Taylors Lane,
Dublin 8,
Ireland.


 Pay by Wire Transfer:
Please transfer funds to:

Account number: 83313083
Sort code: 98-53-30
Swift code: ULSBIE2D
IBAN number: IE78ULSB98533083313083
Bank Address: Ulster Bank,
27-35 Main St,
Blackrock,
Co. Dublin,
Ireland.
If you have a Marketing Code please enter it below:
Marketing Code:


Please note that by ordering from Research and Markets you are agreeing to our Terms and Conditions at http://www.researchandmarkets.com/info/terms.asp

Please fax this form to:
(646) 607-1907 or (646) 964-6609 (from USA)
+353-1-481-1716 or +353-1-653-1571 (from Rest of World)